Atf7ip-KO Mouse
一般名
Atf7ip-KO
製品ID
S-KO-10497
背景情報
C57BL/6JCya
系統ID
KOCMP-54343-Atf7ip-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Atf7ip-KO Mouse(カタログ番号S-KO-10497)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Atf7ip-KO
系統ID
KOCMP-54343-Atf7ip-B6J-VA
遺伝子名
製品ID
S-KO-10497
遺伝子別名
AM, Mcaf1, 2610204M12Rik, 5830415B17Rik
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conventional knockout
染色体
Chr 6
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000032335
NCBIトランスクリプトID
NM_019426
ターゲット領域
Exon 2
有効領域の大きさ
~2.2 kb
遺伝子研究の概要
Atf7ip, also known as activating transcription factor 7 interacting protein, is an epigenetic regulator that plays crucial roles in various biological processes. It is closely associated with the Setdb1 methyltransferase, and together they are involved in pathways such as histone modification and chromatin remodeling, which are vital for maintaining normal cellular functions and development [1,2,3,4,5,6,7,8].
In zebrafish mutants deficient in Atf7ip, there is excessive myeloid differentiation with impaired hematopoietic stem and progenitor cell (HSPC) expansion, leading to a decline in T cells and the erythroid lineage. Atf7ip regulates hematopoiesis through Setdb1-mediated H3K9me3 modification and chromatin remodeling, preventing premature differentiation of HSPCs into the myeloid lineage [1]. In mice with T cell-specific deletion of Atf7ip, there are enhanced CD8+ T cell effector and memory responses due to increased Il7r and Il2 expression, as Atf7ip represses these genes through H3K9me3 deposition at relevant loci [3]. Also, Th17 differentiation is impaired in Atf7ip-deficient T cells, secondary to aberrant overproduction of IL-2 [5]. In MC3T3-E1 cells, overexpression of Atf7ip impairs osteoblast differentiation, while its depletion promotes it, and Atf7ip-deleted mice in osteoblasts show more bone formation [2]. Disrupting Atf7ip in tumor cells restores tumor antigen expression, augmenting tumor immunogenicity [7].
In summary, Atf7ip, often in conjunction with Setdb1, is essential for maintaining the balance of cell differentiation, immune responses, and tumor antigen expression. Studies using gene knockout models in zebrafish and mice have revealed its role in hematopoiesis, T cell function, osteoblast differentiation, and tumor immunity, providing insights into potential interventions for hematological malignancies, bone-related diseases, and cancer immunotherapy [1,2,3,5,7].
References:
1. Wu, Jiaxin, Li, Juan, Chen, Kang, Xie, Peng, Zhong, Tao P. 2022. Atf7ip and Setdb1 interaction orchestrates the hematopoietic stem and progenitor cell state with diverse lineage differentiation. In Proceedings of the National Academy of Sciences of the United States of America, 120, e2209062120. doi:10.1073/pnas.2209062120. https://pubmed.ncbi.nlm.nih.gov/36577070/
2. Hu, Guoqin, Shi, Xian, Qu, Xiuxia, Liu, Huanliang, Wu, Yu. 2023. Atf7ip Inhibits Osteoblast Differentiation via Negative Regulation of the Sp7 Transcription Factor. In International journal of molecular sciences, 24, . doi:10.3390/ijms24054305. https://pubmed.ncbi.nlm.nih.gov/36901736/
3. Sin, Jun Hyung, Kashyap, Sujit, Acenas, Dante, Matloubian, Mehrdad, Waterfield, Michael R. 2022. ATF7ip Targets Transposable Elements for H3K9me3 Deposition to Modify CD8+ T Cell Effector and Memory Responses. In Journal of immunology (Baltimore, Md. : 1950), 208, 1155-1169. doi:10.4049/jimmunol.2100996. https://pubmed.ncbi.nlm.nih.gov/35110421/
4. Tsusaka, Takeshi, Shimura, Chikako, Shinkai, Yoichi. 2019. ATF7IP regulates SETDB1 nuclear localization and increases its ubiquitination. In EMBO reports, 20, e48297. doi:10.15252/embr.201948297. https://pubmed.ncbi.nlm.nih.gov/31576654/
5. Sin, Jun Hyung, Zuckerman, Cassandra, Cortez, Jessica T, Anderson, Mark S, Waterfield, Michael R. 2019. The epigenetic regulator ATF7ip inhibits Il2 expression, regulating Th17 responses. In The Journal of experimental medicine, 216, 2024-2037. doi:10.1084/jem.20182316. https://pubmed.ncbi.nlm.nih.gov/31217192/
6. Kariapper, Leena, Marathe, Ila A, Niesman, Ashley B, Wysocki, Vicki H, Worden, Evan J. 2024. Setdb1 and Atf7IP form a hetero-trimeric complex that blocks Setdb1 nuclear export. In bioRxiv : the preprint server for biology, , . doi:10.1101/2024.12.23.630145. https://pubmed.ncbi.nlm.nih.gov/39764026/
7. Hu, Hai, Khodadadi-Jamayran, Alireza, Dolgalev, Igor, Li, Fei, Wong, Kwok-Kin. 2021. Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity. In Cancer immunology research, 9, 1298-1315. doi:10.1158/2326-6066.CIR-21-0543. https://pubmed.ncbi.nlm.nih.gov/34462284/
8. Timms, Richard T, Tchasovnikarova, Iva A, Antrobus, Robin, Dougan, Gordon, Lehner, Paul J. . ATF7IP-Mediated Stabilization of the Histone Methyltransferase SETDB1 Is Essential for Heterochromatin Formation by the HUSH Complex. In Cell reports, 17, 653-659. doi:10.1016/j.celrep.2016.09.050. https://pubmed.ncbi.nlm.nih.gov/27732843/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
